• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

US Rep. Introduces Product Information Modernization Bill


August 26, 2015.

U.S. Representative Billy Long (R-MO, 7th District) has introduced a bill to update regulations on how drug manufacturers communicate product information.   Long is the lead sponsor of H.R. 2479, which would force FDA to change regulations on how pharma companies share product information with the public. The bill would direct FDA to "clearly regulate meaningful, truthful and non-misleading communication of product information on social media".     "One would think something as important as personal decision-making for healthcare would be easy to get economic and scientific data to back up the drug's effectiveness," said Long. "This bill would simply push FDA to update its regulatory approach to communications to keep up with today's technology."     

Related Videos